Clinical Trials Directory

Trials / Unknown

UnknownNCT04730063

Evaluation of Novel Cardio-Pulmonary Physiological Monitor, the VQm PHM™, for Acute Care Medicine

Prospective Non-Interventional Study Evaluating Non-invasive Measurements of Pulmonary Blood Flow, Functional Residual Capacity, Shunt Fraction Index and Airway Dead Space Measured With the VQm PHM™ to Clinical Gold Standards

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Rostrum Medical Innovations Inc. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This is a prospective, observational study to assess agreement of pulmonary health parameters measured by a new non-invasive physiologic monitor, the VQm pulmonary health monitor (PHM)™ with clinical gold standards.

Detailed description

The specific aim of this study is to evaluate the intermittent non-invasive measurements of pulmonary function: pulmonary blood flow (PBF), functional residual capacity (FRC), shunt fraction index (Qsi) and airway dead space measured by the VQm PHM™ compared to known clinical standards. PBF will be compared to continuous and intermittent bolus thermodilution cardiac output as measured through a Swan-Ganz catheter. FRC will be compared to an FRC measurement provided by a standard nitrogen washout method. Qsi will be compared to shunt fraction calculated through mixed venous and arterial blood gas values (VBGs/ABGs). Airway dead space will be compared to an airway dead space measurement provided by a ventilator.

Conditions

Interventions

TypeNameDescription
DEVICEVQm PHM™Procedure: Non-invasive measurements obtained with the VQm PHM™

Timeline

Start date
2021-02-17
Primary completion
2023-01-01
Completion
2023-02-01
First posted
2021-01-29
Last updated
2022-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04730063. Inclusion in this directory is not an endorsement.